Back to Search Start Over

Biological and biorational management of blast diseases in cereals caused by Magnaporthe oryzae .

Authors :
Chakraborty M
Mahmud NU
Ullah C
Rahman M
Islam T
Source :
Critical reviews in biotechnology [Crit Rev Biotechnol] 2021 Nov; Vol. 41 (7), pp. 994-1022. Date of Electronic Publication: 2021 May 18.
Publication Year :
2021

Abstract

Blast diseases, caused by the fungal pathogen Magnaporthe oryzae , are among the most destructive diseases that occur on at least 50 species of grasses, including cultivated cereals wheat, and rice. Although fungicidal control of blast diseases has widely been researched, development of resistance of the pathogen against commercially available products makes this approach unreliable. Novel approaches such as the application of biopesticides against the blast fungus are needed for sustainable management of this economically important disease. Antagonistic microorganisms, such as fungi and probiotic bacteria from diverse taxonomic genera were found to suppress blast fungi both in vitro and in vivo . Various classes of secondary metabolites, such as alkaloids, phenolics, and terpenoids of plant and microbial origin significantly inhibit fungal growth and may also be effective in managing blast diseases. Common modes of action of microbial biocontrol agents include: antibiosis, production of lytic enzymes, induction of systemic resistance in host plant, and competition for nutrients or space. However, the precise mechanism of biocontrol of the blast fungus by antagonistic microorganisms and/or their bioactive secondary metabolites is not well understood. Commercial formulations of biocontrol agents and bioactive natural products could be cost-effective and sustainable but their availability at this time is extremely limited. This review updates our knowledge on the infection pathway of the wheat blast fungus, catalogs naturally occurring biocontrol agents that may be effective against blast diseases, and discusses their role in sustainable management of the disease.

Details

Language :
English
ISSN :
1549-7801
Volume :
41
Issue :
7
Database :
MEDLINE
Journal :
Critical reviews in biotechnology
Publication Type :
Academic Journal
Accession number :
34006149
Full Text :
https://doi.org/10.1080/07388551.2021.1898325